What we're reading, September 22, 2016: a new bill would cap out-of-pocket costs for Medicare beneficiaries; world leaders agreed to a global effort to curb the spread of superbugs; and Mark Zuckerberg and Priscilla Chan, MD, will donate $3 billion over 10 years to cure disease.
A new bill would cap out-of-pocket costs for seniors in traditional Medicare. According to Morning Consult, the bill is unlikely to pass in a Republican-controlled Congress, but could be a glimpse of the future of Democrats take back control after this election. The Medicare Affordability and Enrollment Act, introduced by Senator Ron Wyden, D-Oregon, would cap out-of-pocket spending for Medicare at $5500, and also expand eligibility among low-income seniors.
The first global effort to stop the spread of drug resistance bacteria is beginning. World leaders have agreed on steps to curb the spread of so-called “superbugs” that are becoming immune to many medicines, reported The New York Times. However, the agreement is nonbinding and has required no commitments to specific targets. Approximately 700,000 people die every year from drug-resistant infections.
A $3 billion donation over 10 years from Mark Zuckerberg and Priscilla Chan, MD, will be used to try to cure, prevent, or manage all diseases by the end of the century. The couple’s philanthropic organization will bring together scientists and engineers with the goal that people get sick less often and are able to better manage diseases, according to STAT. Part of the effort includes $600 million to create a cooperative involving the University of California, San Francisco, the University of California, Berkeley, and Stanford University.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More